Tolerance induction by acylated peptides: Effect on encephalitogenic T cell lines

Journal of Autoimmunity

Volumn 12, Issue 3, 1999, Pages 177-189

  St Louis, Joanne ^a   Zhang, Xiang Ming ^b   Heber Katz, Ellen ^b   Uniyal, Shashi ^a   Robbinson, Deborah ^a   Singh, Bhagirat ^a   Strejan, Gill H ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b WISTAR INSTITUTE   (United States)

Author keywords

Anergy; EAE; MBP peptides; T cell lines

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; IMMUNOLOGICAL TOLERANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

EID: 0032900857     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0275     Document Type: Article

References (51)

1. Arnason B.G. Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol. Clin. 1:1983;765-782.
2. Raine C.S. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab. Invest. 43:1984;150-157.
3. Tsunoda I., Fujinami R.S. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropath. Exp. Neurol. 55:1996;673-686.
4. Holda J., Swanborg R.H. Autoimmune effector cells. II. Transfer of experimental encephalomyelitis with a subset of T lymphocytes. Eur. J. Immunol. 12:1982;453-455.
5. Ben-Nun A., Wekerle H., Cohen I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11:1981;195-199.
6. van der Veen R., Trotter J., Clark H., Kapp J. The adoptive transfer of chronic-relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein. J. Neuroimmunol. 21:1989;183-191.
7. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Jr. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
8. Heber-Katz E., Acha-Orbea H. The V region disease hypothesis: evidence from autoimmune encephalitis. Immunol. Today. 10:1989;164-169.
9. Kuchroo V.K., Collins M., Al-Sabbagh A., Sobel R.A., Witters M.J., Zamvil S.S., Dorf M.E., Hafler D.A., Zaidman J.G., Weiner H.L., Rimm I.J. T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR Vβ8.2 transgenic mice. J. Exp. Med. 179:1994;1659-1664.
10. Sun D., Gold D.P., Smith L., Brostoff S., Coleclough C. Characterization of rat encephalitogenic T cells bearing non-Vβ8 TCR. Eur. J. Immunol. 22:1992;591-594.
11. Alvord E.J., Shaw C.M., Hruby S., Kies M. Encephalitogen-induced inhibition of experimental allergic encephalomyelitis: prevention, suppression and therapy. Ann. NY Acad. Sci. 122:1965;333-345.
12. Weiner H.L. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 18:1997;335-343.
13. Swierkosz J., Swanborg R.H. Immunoregulation of experimental allergic encephalomyelitis: conditions for the induction of suppressor cells and analysis of mechanism. J. Immunol. 119:1977;1501-1506.
14. Gaur A., Wiers B., Liu A., Rothbart J., Fathman C.G. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science. 258:1992;1491-1494.
15. Yu M., Johnson J.M., Tuohy V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1996;1777-1788.
16. Miller S.D., Ian L.J., Pope L., McRae B.L., Karpus W.J. Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis. Int. Rev. Immunol. 9:1992;203-222.
17. Samson M.F., Smilek D.E. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes. J. Immunol. 155:1995;2737-2746.
18. Wauben M.H.M., Boog C.J.P., van der Zee R., Joosten I., Schlief A., van Eden W. Disease inhibition by major histocompatibility complex binding peptide analogues of disease associated epitopes: more than blocking alone. J. Exp. Med. 176:1992;667-677.
19. Wraith D.C., Smilek D.E., Mitchell D.J., Steinman L., McDevitt H.O. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide mediated immunotherapy. Cell. 59:1989;247-255.
20. Strejan G.H., Percy D.H., St Louis J., Surlan D., Paty D.W. Suppression of experimental allergic encephalomyelitis in guinea pigs by liposome-associated human myelin basic protein. J. Immunol. 127:1981;2064-2069.
21. Strejan G.H., Gilbert J.J., St Louis J. Suppression of chronic-relapsing experimental allergic enchephalomyelitis in strain-13 guinea pigs by the administration of liposome-associated myelin basic protein. J. Neuroimmunol. 7:1985;27-41.
22. Avrilionis K., Boggs J.M. Suppression of experimental allergic encephalomyelitis by the encephalitogenic peptide in solution or bound to liposomes. J. Neuroimmunol. 35:1991;201-210.
23. St Louis J., Chan E.L., Singh B., Strejan G.H. Suppression of experimental allergic encephalomyelitis in the Lewis rat, by administration of an acylated synthetic peptide of myelin basic protein. J. Neuroimmunol. 73:1997;90-100.
24. Stein C.S., St Louis J., Gilbert J.J., Strejan G.H. Treatment of spinal cord-induced experimental allergic encephalomyelitis in the Lewis rat with liposomes presenting central nervous system antigens. J. Neuroimmunol. 28:1990;119-130.
25. Zar J.H. Biostatistical analysis. Prentice Hall, Englewood Cliffs, New Jersey. 1974.
26. Zhang X-M., Heber-Katz E. T cell receptor sequences from encephalitogenic T cells in adult Lewis rats suggest an early ontogenic origin. J. Immunol. 148:1992;746-752.
27. Fallis R.J., McFarlin D.E. Chronic relapsing experimental allergic encephalomyelitis. Cytotoxicity effected by a class II restricted T cell line specific for an encephalitogenic epitope. J. Immunol. 143:1989;2160-2165.
28. Smilek D.E., Wraith D.C., Hodgkinson S., Dwivedy S., Steinman L., McDevitt H.O. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA. 88:1991;9633-9637.
29. Jenkins M.K. The ups and downs of costimulation. Immunity. 1:1994;443-446.
30. Jenkins M.K., Burrell E., Ashwell J.D. Antigen presentation by resting B cells. Effectiveness at inducing T cell proliferation is determined by costimulatory signals, not T cell receptor occupancy. J. Immunol. 144:1990;1585-1590.
31. Fuchs E.J., Matzinger P. B cells turn off virgin but not memory T cells. Science. 258:1992;1156-1159.
32. Finkelman F.D., Lees A., Birnbaum R., Gause W.C., Morris S.C. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157:1996;1406-1414.
33. Mueller D.L., Jenkins M.K., Schwartz R.H. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:1989;455-480.
34. Schönrich G., Kalinke U., Momburg F., Malissen M., Schmitt-Verhulst A-M., Malissen B., Hämmerling G.J., Arnold B. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell. 65:1991;293-304.
35. Hämmerling G.J., Schönrich G., Homburg F., Auphan N., Malissen M., Malissen B., Schmitt-Verhulst A-M., Arnold B. Non-deletional mechanisms of peripheral and central tolerance: Studies with transgenic mice with tissue-specific expression of a foreign MHC class-I antigen. Immunol. Rev. 122:1991;47-67.
36. Valitutti S., Müller S., Cella M., Padovan E., Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature. 375:1995;148-151.
37. Chen Y-Z., Matsushita S., Nishimura Y. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide. Characterization and frequency of TCR agonism and TCR antagonism with or without partial activation. J. Immunol. 157:1996;3783-3790.
38. Ohashi P.S., Oehen S., Buerki K., Pircher H., Ohashi C.T., Odermatt B., Malissen B., Zinkernagel R.M., Hengartner H. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:1991;305-317.
39. +T cells is transient and depends on TCR avidity. J. Immunol. 155:1995;2339-2349.
40. Perez V.L., Van Parijs L., Biukians A., Zheng X.X., Strom T.B., Abbas A.K. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 6:1997;411-417.
41. Jones L.A., Chin L.T., Longo D.L., Kruisbeek A.M. Peripheral clonal elimination of functional T cells. Science. 250:1990;1726-1729.
42. Critchfield J.M., Racke M.K., Zú|$$|Ahniga-Pflücker J.C., Cannella B., Raine C.S., Raine C.S., Goverman J., Lenardo M.J. T cell deletion in high antigen dose therapy of Autoimmune encephalomyelitis. Science. 263:1994;1139-1143.
43. Ferber I., Schönrich G., Schenkel J., Mellor A.L., Hämmerling G.J., Arnold B. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science. 263:1994;674-676.
44. Chen Y., Kuchroo V.K., Inobe J-I., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
45. De Magistris M.T., Alexander J., Coggeshall M., Altman A., Gaeta I.C.A., Grey H.M., Sette A. Antigen analog - major histocompatibility complexes act as antagonists at the T cell receptor. Cell. 68:1992;625-634.
46. Racioppi L., Ronchese F., Matis A., Germain R.N. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1993;1047-1060.
47. Sloan-Lancaster J., Evavold B.D., Allen P.M. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature. 363:1993;156-159.
48. Zhou S.R., Moscarello M.A., Whitaker J.N. The effects of citrullinilation or variable amino-terminus acylation on the encephalitogenicity of human myelin basic protein in the PL/J mouse. J. Neuroimmunol. 62:1995;147-152.
49. Claman H.N., Miller S.D. Requirement for induction of T cell tolerance to DNFB: efficiency of membrane-associated DNFB. J. Immunol. 117:1976;480-485.
50. Ria F., Chan B.M.C., Scherer M.T., Smith J.A., Gefter M.L. Immunological activity of covalently linked T-cell epitopes. Nature. 343:1990;381-383.
51. Bachmann M.F., Fehr T., Freer G., Hengartner H., Zinkernagel R.M. Correlation of tolerogenicity of a viral antigen with its immunogenicity. J. Immunol. 158:1997;5106-5111.